Regenxbio Inc (RGNX)

Exchange
NASDAQ
Symbol
RGNX
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies intended to affect disease. The company is headquartered in Rockville, Maryland.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    7.77
  • High
    8.03
  • Low
    7.51
  • Close
    7.82
  • Volume
    1,022,220

Financial ratios

Dec 31, 2023